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ABSTRACT 
With the discovery of various antibiotic resistant bacteria, evaluations of antimicrobial activities of natural compounds have 
been preceded on antibiotic susceptible and resistant microorganisms. Several types of natural compounds have been reported 
to have similar effects on target microorganisms as compared to the widely used antibiotics. Persicaria thunbergii 
(Polygonaceae) has been known to have anti-tumoral, anti-angiogenesis, anti-oxidation and anti-inflammation functions. In 
this study, aerial parts of P. thunbergii were extracted using methanol, chloroform, and ethyl acetate to identify possible anti-
bacterial effects. Agar disk diffusion method and time-kill assay were done to evaluate the antibacterial effect of P. thunbergii 
extracts. Two extracts ethyl acetate (EAE), and chloroform (CFE) were tested against Staphylococcus aureus. As a result, the 
extract from CFE and EAE showed antibacterial effect against S. aureus. The extract EAE showed the strongest inhibition effect 
compared to CFE. These results demonstrate that the EAE extract which originated from P. thunbergii can probably play a role 
as an antibacterial agent. 
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INTRODUCTION 
Development of antibiotic resistance in bacteria is a critical 
issue in the controlling of infectious diseases [1, 2]. 
Therefore, antibacterial agents are needed to be found and 
apply to control multi-drugs resistant bacteria [3]. There 
has been growing interests to find antimicrobial 
compounds with different mechanism of action from 
natural resources such as plant extracts as an alternative 
approach to deal with this problem [4]. In recent years, the 
Staphylococcus aureus has been identified as a resilient 
and resistant pathogen [1, 4]. The hospitals outbreak of 
multi-drug resistant S. aureus has been reported 
worldwide. Only ∼ 20 % of the S. aureus strains remain 
sensitive to penicillin [4], ∼ 60 % of the S. aureus clinical 
isolated strains in United State of America shows 
resistance to methicillin [5]. The failure of existing 
antibiotics in controlling the S. aureus infections has 
increased interest in finding an alternative treatment. The 
natural resource such as medicinal plants plays a 
significant role in primary healthcare system. The plants 
extract contains different phytochemicals such as 
alkaloids, steroids, flavonoids, proteins, tannins, phenolic 
compounds; and secondary metabolites which plays a 
defensive work against foreign infectious agents to protect 
plant.  
The Persicaria thunbergii is an herb with 30-100 cm height 
and long petioles with wings; belongs to family Polygonaceae. 
This plant is famous in Korea and China for folk medicinal 
uses in curing rheumatism, measles and hemorrhage. P. 
thunbergii is a medicinal plant; recently significant activities 
reported in biomedical applications such as, anti-tumoral [6], 
isorhamnetin induced-apoptosis [7], anti-oxidation [8], anti-
inflammation [9], anti-angiogenesis [10], and flavonoids from 
P. thunbergii reported as a acetylcholinesterase inhibitor [11]. 
However, to date, there is no data on antibacterial activity of 
P. thunbergii on pathogenic bacteria. Thus, the present study 
aimed to determine the antibacterial activity of P. thunbergii 
different extract on Staphylococcus aureus bacteria.  
MATERIALS AND METHODS 
Materials 
The aerial part of P. thunbergii was collected from Yangsa, 
Gyeongnam in Korea. Mueller-Hinton Agar (MHA) and 
Brain Heart Infusion (BHI) broth were obtained from BD 
diagnostic, Le Pont De Claix, France. Staphylococcus 
aureus ATCC6538P was procured from Korean Culture 
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Center of Microorganisms (KCCM). 
Plant material extraction and fractionation 
Sample extract preparation and separation process 
perform as described previously with minor modifications 
[9]. In brief, the aerial part of P. thunbergii was dried at 
room temperature and powder was prepared using electric 
grinder. The prepared powder was soaked in methanol at 
room temperature, after 4 w residue separated by 
filtration. The filtrate was concentrated in vacuum 
condition. After that, methanol extract was fractioned with 
chloroform using separation funnel. Consequently, ethyl 
acetate extracts were fractioned using the same method. 
Each extracts were adsorbed on the silica gel and followed 
separation by automated flash chromatography system 
(MPLC; Combifresh-RF. ISCO) and samples dried under 
vacuum condition. 
Disk diffusion assay 
This method was performed as per CLSI guideline description 
[12]. S. aureus were separately inoculated in tube containing 5 
ml BHI broth, and incubated at 37 °C for 4 h in rotary shaking 
incubator. After incubation, 100 µl of each of the bacterial 
suspension approximately 105 CFU. ml-1 were spreaded over 
the surface of MHA plate using sterile glass spreader. Paper 
disk (8 mm diameter), were dropped with 10 µg penicillin and 
different concentrations (1, 3, and 5 mg) of P. thunbergii ethyl 
acetate extract (EAE) and chloroform extracts (CFE) 
separately. After that, paper disk placed in four corners on the 
surface of MHA plates inoculated with bacteria and incubated 
at 37 °C for 17 h. After incubation diameter of bacterial growth 
inhibition surrounding the paper disk called zone of 
inhibition (ZOI) were measured in mm.  
Bacterial viability test 
The S. aureus suspension was prepared as mentioned in 
previous test. Six tubes with 5 ml BHI broth were prepared 
and inoculated with S. aureus suspension. First tube was 
set as a control, and in second tube 20 µl of 
dimethylsulfoxide (DMSO) was added. After which 20 µl of 
EAE and CFE with a concentration 400 and 800 µg. ml-1 
were added, respectively to each of the remaining tubes. 
All the tubes were incubated at 37 °C for 17 h. After that, 
serial dilutions were prepared from 10-1 to 10-7. Then, 100 
µl of 10-6 and 10-7 dilutions were separately spreaded over 
the surface of BHI agar in duplicates. All plates after 
spreading were incubated at 37 °C for 17 h. The former 
colonies on the agar plates were counted to determined 
which samples were to be subjected to time kill assay. 
Time kill assay 
Seven tubes with 5 ml BHI broth were prepared. All tubes 
were inoculated with S. aureus. One tube was set as a 
control, and in another tube 20 µl of dimethylsulfoxide 
(DMSO) was added. After which 20 µl of EAE and CFE with 
a concentration 400 µg. ml-1 were added to 2 tubes, 
respectively. The remaining 3 tubes were added with a 
concentration 400 µg. ml-1 of the EAE fractions (EAE1, 
EAE2, and EAE3) separately. All tubes were incubated at 
37°C and optical density (OD) at 620 nm was observed at 
interval of every 4 h up to 24 h. 
RESULTS AND DISCUSSION 
The P. thunbergii extracts were screened for antibacterial 
susceptibility by disk diffusion method against S. aureus, 
the concentration dependent ZOI were observed against S. 
aureus. Fig.1 (a) indicates ZOI around disk contains (1) 
Penicillin10 µg, (2, 3, and 4) 1, 3, and 5 mg of EAE 
respectively, likewise, Fig.1 (b) indicates ZOI around disk 
contains (1) Penicillin10 µg (2, 3, and 4), 1, 3, and 5 mg of 
CFE, respectively. Penicillin shows ZOI (14 mm) smaller 
than EAE, and CFE. ZOI for EAE were recorded 17, 22, and 
24 mm at concentration per disk was 1, 5 and 5 mg, 
respectively. While, ZOI for CFE were observed 22, 23, and 
24 mm at 1, 3 and 5 mg per disk, respectively. 
 
 
Fig. 1: Zone of inhibition of Persicaria thunbergii 
extracts (a) Ethyl acetate extract and (b) 
Chloroform extract on Staphylococcus aureus 
 
 
 
Fig. 2: Persicaria thunbergii extracts exhibits concentration dependent antibacterial susceptibility against 
Staphylococcus aureus. (DMSO-Dimethylsulfoxide, EAE-Ethyl acetate extract, CFE-Chloroform extract) 
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The bacterial viability test was performed against S. aureus 
by spread plate method. The P. thunbergii extracts were 
observed concentration dependent antibacterial activity. 
EAE and CFE treated bacterial suspension tubes, after 
incubation were subjected to serial dilution and spreaded on 
agar surface to develop colonies for determining bactericidal 
effect. Fig. 2 indicates, Untreated (control) and DMSO 
containing bacterial suspension (10-8), EAE, and CFE 
treated bacterial suspension (10-7, 10-8) at 400 and 500 µg. 
ml-1 concentrations were developed colonies. The number of 
colonies counted (table 1) and indicated the S. aureus were 
concentration dependent susceptible; EAE shows strong 
bactericidal effect compared to CFE at both concentrations. 
After P. thunbergii extracts treated bacterial viability 
check, 400 µg. ml-1 EAE and CFE were used to 
determine the time dependent bactericidal effect. Time 
kill assay were performed by spectroscopic method. 
Fig.3 indicates the untreated (control) and DMSO 
containing bacterial suspension shows time dependent 
increased absorbance at 600 nm indicates 
multiplication of bacteria, comparatively EAE and CFE 
shows less absorbance. The EAE shows more bacteria 
killing potential than CFE. 
The P. thunbergii aerial part contains flavonoids and 
flavonoids glycosides such as isorhamnetin, quercetin, and 
shows potential anticancer, antitumor and anti-oxidant 
activity without any toxic effect on human cells [6, 9-11]. 
Flavonoids are the good source as an antibacterial agent 
[13], and due to non-toxic nature and natural resource P. 
thunbergii extract can be useful as a new antibacterial 
agent. Other members of genus Persicaria, such as P. 
odorata [14] and P. minor (Huds.) [15] were reported for 
their potential antimicrobial activity. This is the first 
reporting for antibacterial potential of P. thunbergii 
against S. aureus. Overall, P. thunbergii EAE has good 
antibacterial activity against S. aureus, the 
phytocomposition and exact mechanism behind S. aureus 
growth inhibition needs more detail studies.  
CONCLUSION 
In conclusion, plant extracts have great potential as 
antimicrobial agent. Thus, it can be used in treating of 
infectious diseases caused by pathogenic bacteria. In this 
study, extracts of P. thunbergii was found to exhibit 
antibacterial effects on S. aureus. However the mechanism 
of antibacterial properties of P. thunbergii extract is still 
unknown. These findings suggest that the extract from P. 
thunbergii is can be useful in healthcare and medicines as 
an antibacterial agent. 
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Table 1: Bacterial viability test. P. thunbergii EAE and CFE shows concentration dependent S. aureus 
inhibition. (DMSO-Dimethylsulfoxide, EAE-Ethyl acetate extract, CFE-Chloroform extract, and TNTC-Too 
numerous to count) 
Dilution Control DMSO EAE 400 µg. 
ml-1 
EAE 800 µg. 
ml-1 
CFE 400 µg. 
ml-1 
CFE 800 µg. 
ml-1 
10-7 TNTC TNTC 81 36 196 51 
10-8 236 231 9 2 26 5 
 
 
 
 
Fig. 3: Time kill assay. Persicaria thunbergii EAE and CFE shows time dependent Staphylococcus aureus 
inhibition. (DMSO-Dimethylsulfoxide, EAE-Ethyl acetate extract, CFE-Chloroform extract, and TNTC-Too 
numerous to count) 
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